Recombinant human growth hormone improves growth in children receiving glucocorticoid treatment after liver transplantation

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 4, 1996, Pages 1476-1482

  Sarna, Samu ^a   Sipilä, Ilkka ^a   Rönnholm, Kai ^a   Koistinen, Riitta ^a   Holmberg, Christer ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; HUMAN GROWTH HORMONE; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; RECOMBINANT GROWTH HORMONE;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; FEMALE; GRAFT REJECTION; GROWTH ACCELERATION; GROWTH RETARDATION; GROWTH STIMULATION; HORMONAL THERAPY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

AZATHIOPRINE; CHILD; CYCLOSPORINE; DRUG MONITORING; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GROWTH; GROWTH DISORDERS; GROWTH HORMONE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; LIVER FUNCTION TESTS; LIVER TRANSPLANTATION; MALE; METHYLPREDNISOLONE; MONITORING, PHYSIOLOGIC; RECOMBINANT PROTEINS; STATISTICS, NONPARAMETRIC;

EID: 0029986841     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.4.1476     Document Type: Article

References (45)

1. Esquivel CO, Martinez O, Krams S, et al. 1994 Liver transplantation at California Pacific Medical Center, San Francisco, California. In: Terasaki PI, Cecka JM, eds. Clinical transplants 1994. Los Angeles: University of California-Los Angeles Tissue Typing Laboratory; 163-171.
2. Codoner-Franch P, Bernard O, Alvarez F. 1994 Long-term follow-up of growth in height after successful liver transplantation. J Pediatr. 124:368-373.
3. Sarna S, Sipilä I, Vihervuori E, Koistinen R, Holmberg C. 1995 Growth delay after liver transplantation in childhood: studies of underlying mechanisms. Pediatr Res. 38:366-372.
4. Urbach AH, Gartner JC, Malatack JJ, et al. 1987 Linear growth following pediatric liver transplantation. Am J Dis Child. 141:547-549.
5. Moukarzel AA, Najm I, Vargas J, McDiarmid SV, Busuttil RW, Ament ME. 1990 Prediction of long-term linear growth following liver transplantation. Transplant Proc. 22:1558-1559.
6. Sarna S, Sipilä I, Jalanko H, Laine J, Holmberg C. 1994 Factors affecting growth after pediatric liver transplantation. Transplant Proc. 26:161-164.
7. Sarna S, Laine J, Sipilä I, Koistinen R, Holmberg C. 1995 Differences in linear growth and cortisol production between liver and renal transplant recipients on similar immunosuppression. Transplantation. 60:656-661.
8. Tönschoff B, Haffner D, Mehls O, et al. 1993 Efficacy and safety of growth hormone treatment in short children with renal allografts: three year experience. Kidney Int. 44:199-207.
9. Miell JP, Taylor AM, Jones J, et al. 1993 The effects of dexamethasone treatment on immunoreactive and bioactive insulin-like growth factors (IGFs) and IGF-binding proteins in normal male volunteers. J Endocrinol. 136:525-533.
10. Bang P, Degerblad M, Thoren M, Schwandler J, Blum W, Hall K. 1993 Insulin-like growth factor (IGF) I and II, and IGF binding protein 1, 2 and 3 in serum from patients with Cushing's syndrome. Acta Endocrinol (Copenh). 128:397-404.
11. Chavers BM, Doherty L, Nevins TE, Cook M, Sane K. 1995 Effects of growth hormone on kidney function in pediatric transplant recipients. Pediatr Nephrol. 9:176-181.
12. Sorva R, Lankinen S, Tolppanen EM, Perheentupa J. 1990 Variation of growth in height and weight of children. Acta Paediatr Scand. 79:498-506.
13. Durant R, Linder EW. 1981 An evaluation of 5 indexes of relative body weight for use with children. J Am Diet Assoc. 78:35-38.
14. Tanner JM, Whitehouse RH. 1976 Longitudinal standards for height, weight-height, weight-velocity and stages of puberty. Arch Dis Child. 51: 170-179.
15. Tanner JM, Whitehouse RH, Cameron N, Marshall WA, Healy MJR, Goldstein H. 1983 Assessment of skeletal maturity and prediction of adult height (TW2 method), 2nd ed. London: Academic Press.
16. Albertsson-Wikland K, Rosberg S. 1988 Analyses of 24-hour growth hormone profiles in children: relation to growth. J Clin Endocrinol Metab. 67:493-500.
17. Koistinen H, Seppälä M, Koistinen R. 1994 Different forms of insulin-like growth factor-binding protein-3 detected in serum and seminal plasma by immunofluorometric assay with monoclonal antibodies. Clin Chem. 40:531-536.
18. Oellerich M, Rande E, Burdelski M, et al. 1987 Monoethylglycinexylidide formation kinetics: a novel approach to assessment of liver function. J Clin Chem Clin Biochem. 25:845-853.
19. Hill MR, Szefler SJ, Ball BD, Bartoszek M, Brenner AM. 1990 Monitoring glucocorticoid therapy: a pharmacokinetic approach. Clin Pharmacol Ther. 48:390-398.
20. Frantz AG, Rabkin MT. 1969 Human growth hormone: clinical measurement, response to hypoglycemia and suppression by corticosteroids. N Engl J Med. 271:1375-1381.
21. Gabrielsson BG, Carmignac DF, Flavell DM, Robinson ICAF. 1995 Steroid regulation of growth hormone (GH) receptor and GH-binding protein messenger ribonucleic acids in the rat. Endocrinology. 136:209-217.
22. Luo J, Murphy LJ. 1989 Dexamethasone inhibits growth hormone induction of insulin-like growth factor-I (IGF-I) messenger ribonucleic acid (mRNA) in hypophysectomized rats and reduces IGF-I mRNA abundance in the intact rat. Endocrinology. 125:165-171.
23. Unterman TG, Phillips LS. 1985 Glucocorticoid effects on somatomedins and somatomedin inhibitors. J Clin Endocrinol Metab. 61:618-626.
24. Baron J, Huang Z, Oerter KE, Bacher JD, Cutler Jr GB. 1992 Dexamethasone acts locally to inhibit longitudinal bone growth in the rabbit. Am J Physiol. 263:E489-E492.
25. Wehrenberg WB, Bergman PJ, Stagg L, Ndon J, Giustina A. 1990 Glucocorticoid inhibition of growth in rats: partial reversal with somatostatin antibodies. Endocrinology. 127:2705-2708.
26. Spiliotis BE, August GP, Hung W, Sonis W, Mendelson W, Bercu BB. 1984 Growth hormone neurosecretory dysfunction: a treatable cause for short stature. JAMA. 251:2223-2230.
27. Benfield MR, Parker KL, Waldo FB, Overstreet SL, Kohaut EC. 1993 Treatment of growth failure in children after renal transplantation. Transplantation. 55:305-308.
28. Cacciari E, Tassoni P, Cicognani, et al. 1994 Value and limits of pharmacological and physiological tests to diagnose growth hormone (GH) deficiency and predict therapy response: first and second retesting during replacement therapy of patients defined as GH deficient. J Clin Endocrinol Metab. 79:1663-1669.
29. Jones JI, Clemmons DR. 1995 Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev. 16:3-34.
30. Giustina A, Girelli A, Alberti D, et al. 1991 Effects of pyridostigmine on spontaneous and growth hormone-releasing hormone stimulated growth hormone secretion in children on daily glucocorticoid therapy after liver transplantation. Clin Endocrinol (Oxf). 35:491-498.
31. Mandel S, Moreland E, Nichols V, Hanna C, Lafranchi S. 1995 Changes in insulin-like growth factor-I (IGF-I), IGF-binding protein-3, growth hormone (GH)-binding protein, erythrocyte IGF-I receptors, and growth rate during GH treatment. J Clin Endocrinol Metab. 80:190-194.
32. Fine RN, Yadin O, Nelson PA, et al. 1991 Recombinant human growth hormone treatment of children following renal transplantation. Pediatr Nephrol. 5:147-151.
33. Hokken-Koelega ACS, Stijnen T, de Ridder MAJ, et al. 1994 Growth hormone treatment in growth-retarded adolescents after renal transplant. Lancet. 343:1313-1317.
34. Zadik Z, Chalew S, Zung A, et al. 1994 Effect of long-term growth hormone therapy on bone age and pubertal maturation in boys with and without classic growth hormone deficiency. J Pediatr. 125:189-195.
35. Horber FF, Haymond MW. 1990 Human growth hormone prevents the protein catabolic side effects of prednisone in humans. J Clin Invest. 86:265-272.
36. Allen DB, Goldberg BD. 1992 Stimulation of collagen synthesis and linear growth by growth hormone in glucocorticoid-treated children. Pediatrics. 89:416-421.
37. Bartosh S, Kaiser B, Rezvani I, et al. 1992 Effects of growth hormone administration in pediatric renal allograft recepients. Pediatr Nephrol. 6:68-73.
38. Janssen F, Van Damme-Lombaerts R, Van Dyck M, et al. 1993 Effects of recombinant human growth hormone on graft function in renal-transplanted children and adolescents: the three-year experience of a Belgian study group. Transplant Proc. 25:1049-1050.
39. Van Es A. 1991 Growth hormone treatment in short children with chronic renal failure and after renal transplantation: combined data from European clinical trials. Acta Paediatr Scand. 379(Suppl):42-48.
40. Van Dop C, Jabs KL, Donohoue PA, Bock GH, Fivush BA, Hannon WE. 1992 Accelerated growth rates in children with growth hormone after renal transplantation. J Pediatr. 120:244-250.
41. Giustina A, Bussi AR, Jacobello C, Wehrenberg WB. 1995 Effects of recombinant human growth hormone on bone and intermediary metabolism in patients receiving chronic glucocorticoid treatment with suppressed endogenous GH response to GH-releasing hormone. J Clin Endocrinol Metab. 80: 122-129.
42. Laine J, Krogerus L, Sarna, S, Jalanko H, Rönnholm K, Holmberg C. Recombinant human growth hormone treatment: effect on renal allograft function and histopathology. Transplantation. In press.
43. Rizza RA, Mandarino LJ, Gerich JE. 1982 Effects of growth hormone on insulin action in man: mechanisms of insulin resistance, impaired suppression of glucose production, and impaired stimulation of glucose utilization. Diabetes. 31:663-669.
44. Olefsky JM, Kimmerling A. 1976 Effect of glucocorticoids on carbohydrate metabolism. Am J Med Sci. 271:202-210.
45. Horber FF, Marsh HM, Haymond MW. 1991 Differential effects of prednisone and growth hormone on fuel metabolism and insulin antagonism in humans. Diabetes. 40:141-149.